Bajonaid Amal, Guntaka Praveen Kumar, Harper Matthew, Cutler Corey, Duncan Christine, Villa Alessandro, Sroussi Hervé Y, Woo Sook-Bin, Treister Nathaniel S
College of Dentistry, Jazan University, Jazan, Saudi Arabia.
OMFS Candidate, Mount Sinai Health System, New York, New York, USA.
Oral Dis. 2024 Nov;30(8):5082-5090. doi: 10.1111/odi.14932. Epub 2024 Mar 21.
Chronic graft-versus-host disease (cGVHD) is a leading cause of morbidity and mortality following allogeneic hematopoietic cell transplantation (alloHCT). The sclerodermatous form of cGVHD can be particularly debilitating; however, orofacial sclerodermatous involvement remains poorly described.
To characterize orofacial features of sclerodermatous cGVHD in a single center cohort of patients who underwent alloHCT.
Retrospective data were collected from electronic medical records and analyzed descriptively.
There were 39 patients who received alloHCT between 1993 and 2017 and developed orofacial sclerodermatous cGVHD. Concomitant cutaneous sclerodermatous cGVHD was common (n = 20, 51%). Orofacial sclerodermatous cGVHD features included fibrous bands of the buccal mucosa (n = 23, 59%), limited mouth opening (n = 19, 54%), perioral fibrosis (n = 8, 21%), and focal gingival recession (n = 4, 10%). Oral mucosal fibrosis was observed at the site of active or resolved chronic lichenoid inflammation in 30 patients, with all but two also presenting with a history of ulcerations. Management included jaw stretching exercises (n = 10; 6 stable/improved), surgery (n = 3; 2 improved), and intralesional corticosteroid injections (n = 2; 2 improved).
Orofacial involvement with sclerodermatous cGVHD can present with multiple manifestations including fibrous banding, limited mouth opening, perioral fibrosis, and focal gingival recession. Surgical and non-surgical management strategies may improve clinical function and reduce morbidity.
慢性移植物抗宿主病(cGVHD)是异基因造血细胞移植(alloHCT)后发病和死亡的主要原因。cGVHD的硬皮病形式可能特别使人衰弱;然而,口面部硬皮病累及情况仍描述甚少。
在接受alloHCT的单中心队列患者中,描述硬皮病性cGVHD的口面部特征。
从电子病历中收集回顾性数据并进行描述性分析。
1993年至2017年间有39例接受alloHCT并发生口面部硬皮病性cGVHD的患者。伴有皮肤硬皮病性cGVHD很常见(n = 20,51%)。口面部硬皮病性cGVHD特征包括颊黏膜纤维带(n = 23,59%)、张口受限(n = 19,54%)、口周纤维化(n = 8,21%)和局限性牙龈退缩(n = 4,10%)。30例患者在活动性或已消退的慢性苔藓样炎症部位观察到口腔黏膜纤维化,除2例患者外均有溃疡病史。治疗包括颌骨伸展运动(n = 10;6例病情稳定/改善)、手术(n = 3;2例改善)和病灶内注射皮质类固醇(n = 2;2例改善)。
口面部硬皮病性cGVHD累及可表现为多种形式,包括纤维带形成、张口受限、口周纤维化和局限性牙龈退缩。手术和非手术治疗策略可能改善临床功能并降低发病率。